论文信息 - A Phase III open-label, randomized, active controlled clinical study to assess safety, immunogenicity and lot-to-lot consistency of a bovine-human reassortant pentavalent rotavirus vaccine in Indian infants - 字舞流文

A Phase III open-label, randomized, active controlled clinical study to assess safety, immunogenicity and lot-to-lot consistency of a bovine-human reassortant pentavalent rotavirus vaccine in Indian infants

G. Kang | N. Gogtay | A. Dubey | Yuxiao Tang | S. Juvekar | A. Bavdekar | Smilu Mohanlal | P. Kulkarni | S. Babji | S. Lalwani | J. Flores | H. Rajani | A. Kondekar | S. Palkar | R. Munshi | N. Ganguly | R. Kundu | D. Narayanappa | J. Venkateswara Rao | S. Desai | R. Ghildiyal | Dipti Kumbhar | N. Rathi | B. Gunale | P. Niyogi | Kalpana Antony | A. Kawade | Padmasani Venkatramanan | A. Dharmadhikari | P. Venugopal | P. Shetty | Kheya Ghosh Uttam | Mukesh C Agarwal

[1] N. Gogtay,et al. Non-interference of Bovine-Human reassortant pentavalent rotavirus vaccine ROTASIIL® with the immunogenicity of infant vaccines in comparison with a licensed rotavirus vaccine☆ , 2018, Vaccine.

[2] M. Bhan,et al. A Phase 4, multicentre, randomized, single-blind clinical trial to evaluate the immunogenicity of the live, attenuated, oral rotavirus vaccine (116E), ROTAVAC®, administered simultaneously with or without the buffering agent in healthy infants in India , 2018, Human vaccines & immunotherapeutics.

[3] G. Kang,et al. A randomized Phase III clinical trial to assess the efficacy of a bovine-human reassortant pentavalent rotavirus vaccine in Indian infants , 2017, Vaccine.

[4] E. Burnett,et al. Effectiveness of Rotavirus Vaccination: A Systematic Review of the First Decade of Global Postlicensure Data, 2006–2016 , 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[5] R. Montesano,et al. Impact of rotavirus vaccination on child mortality, morbidity, and rotavirus-related hospitalizations in Bolivia. , 2017, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[6] J. Tate,et al. Impact and cost-effectiveness of rotavirus vaccination in Bangladesh , 2017, Vaccine.

[7] S. Gairola,et al. Stability of heat stable, live attenuated Rotavirus vaccine (ROTASIIL®). , 2017, Vaccine.

[8] R. Grais,et al. Efficacy of a Low‐Cost, Heat‐Stable Oral Rotavirus Vaccine in Niger , 2017, The New England journal of medicine.

[9] B. M. Machado,et al. The impact of rotavirus vaccination on emergency department visits and hospital admissions for acute diarrhea in children under 5 years. , 2016, Revista da Associacao Medica Brasileira.

[10] L. Cuevas,et al. Effectiveness of rotavirus vaccines against rotavirus infection and hospitalization in Latin America: systematic review and meta-analysis , 2016, Infectious Diseases of Poverty.

[11] J. Tate,et al. Global, Regional, and National Estimates of Rotavirus Mortality in Children <5 Years of Age, 2000-2013. , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[12] P. Kulkarni,et al. Bovine rotavirus pentavalent vaccine development in India. , 2014, Vaccine.

[13] S. Bhave,et al. Immunogenicity and safety of the pentavalent human-bovine (WC3) reassortant rotavirus vaccine (PRV) in Indian infants , 2013, Human vaccines & immunotherapeutics.

[14] S. Taneja,et al. A dose-escalation safety and immunogenicity study of live attenuated oral rotavirus vaccine 116E in infants: a randomized, double-blind, placebo-controlled trial. , 2009, The Journal of infectious diseases.

[15] G. Kang,et al. Immunogenicity, reactogenicity and safety of human rotavirus vaccine (RIX4414) in Indian infants , 2009, Human vaccines.

[16] D. Stallknecht. FACT SHEET , 2006 .

[17] A. Kapikian,et al. Rotavirus vaccines. , 1992, Biotechnology.